The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Semantic Variant Primary Progressive Aphasia (svPPA)

Neurodegenerative dementia syndrome characterized by progressive loss of word meaning, object knowledge, and surface dyslexia, typically caused by left anterior temporal lobe atrophy and most commonly underlying TDP-43 type C pathology in the FTLD spectrum.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Nöroloji department. Book Appointment →

What is Semantic Variant Primary Progressive Aphasia (svPPA)?

Primary progressive aphasia (PPA) is a focal neurodegenerative syndrome where language is the primary impairment for at least the first two years; semantic variant (svPPA) is one of three classic subtypes alongside non-fluent (nfvPPA) and logopenic (lvPPA) variants.

svPPA is defined by impaired single-word comprehension and impaired object knowledge with relative preservation of speech production fluency, repetition, and motor speech; underlying pathology is most often TDP-43 type C, less commonly Alzheimer's pathology or rare tauopathies.

Imaging shows asymmetric anterior temporal lobe atrophy (left greater than right in 70%, right greater in 30%); right-predominant cases manifest with prosopagnosia, behavioral changes, and emotional empathy deficits resembling behavioral-variant frontotemporal dementia.

Symptoms

Progressive word-finding difficulty with substitution of broad superordinate terms (e.g., 'thing', 'animal' for specific items)
Loss of word meaning — patient cannot define common words, may ask 'what is a cat?' when shown one
Surface dyslexia — regular words read normally but irregular spelling-to-sound words read phonetically (e.g., 'pint' as 'pin-t')
Object naming and recognition impaired despite intact vision; semantic memory loss for facts, people, places
Relative preservation of episodic memory, syntax, repetition, and motor function early; later behavioral and disinhibition symptoms
Right temporal predominant cases — prosopagnosia, loss of person knowledge, mental flexibility decline, atypical food preferences

Risk Factors

Age 50–70 typical onset; less common before 50 or after 75
Family history of frontotemporal dementia or motor neuron disease (5–10% of svPPA familial)
GRN, MAPT, or C9orf72 mutation in familial cases (less common in svPPA than other FTD)
Male sex slight predominance
Higher education paradoxically may be associated with later detection; cognitive reserve effect
No specific environmental risk factors identified

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Progressive word-finding or comprehension difficulty without prominent memory loss — neurology referral for cognitive evaluation
  • Difficulty recognizing familiar faces or family members (prosopagnosia) — neurology with neuropsychology assessment
  • Behavioral changes, dietary fixations, ritualistic behavior, declining empathy — multidisciplinary FTD center
  • Family history of FTD or ALS with new cognitive symptoms — genetic counseling
  • Caregiver burden, safety concerns at home, swallowing difficulties — case management and dementia care planning

Treatment Methods

01
No disease-modifying treatment available; supportive and symptomatic management is primary
02
Speech and language therapy with semantic feature analysis, generative naming exercises, environmental modifications, and communication strategy training
03
Cognitive and behavioral support: simplified communication, picture-aided cards, photo identification of family members, structured daily routines
04
Treatment of comorbid depression with SSRI when appropriate; avoid antipsychotics due to FTD sensitivity to side effects
05
Care planning: legal and financial planning early due to insight loss, caregiver education, eventual long-term care; participate in clinical trials of anti-TDP-43 or progranulin-modifying therapies when eligible

Which Department to Visit?

You can visit our Nöroloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Nöroloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Headache and Migraine

Nöroloji

What you need to know about headache types, migraine attacks, and triggering factors.

Low Back Pain

Nöroloji

Learn about the most common causes of low back pain, risk factors, and appropriate treatment approaches.

Neck Pain and Cervical Disc Herniation

Nöroloji

Learn about the symptoms and treatment options for cervical disc herniation and problems in the neck region.

Epilepsy

Nöroloji

Accurate information about epilepsy, types of seizures, and recommendations for patients and families.

Parkinson Disease

Nöroloji

Parkinson disease is caused by progressive degeneration of dopaminergic neurons and alpha-synuclein accumulation; well-timed therapy substantially improves function and quality of life.

Alzheimer's Disease and Dementia

Nöroloji

Information about early signs, diagnosis, and the care process for Alzheimer's and other types of dementia.

Multiple Sclerosis (MS)

Nöroloji

What is multiple sclerosis, who is at risk, and which treatments are applied?

Stroke

Nöroloji

What is stroke, what are the FAST signs, and why is emergency intervention critical?

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.